Inhibition of fibulin-3 reduces immunosuppressive signaling and enhances macrophage activation in glioblastoma, suggesting a potential therapeutic target.
Fibulin-3 regulates the expression of immunomodulatory signals in GBM cells via NF-κB signaling. A, Expression of CSF-1 mRNA in U251MG cells cotransfected with fibulin-3 cDNA and p65/RelA siRNA, or their respective controls. B–D, Expression of CSF-1 (B), CD47 (C), and TGF-β1 (D) in control and fibulin-3–overexpressing U251MG cells in presence of the NF-κB inhibitor, CAPE (20 μmol/L), or its vehicle. E, Expression of CSF-1 mRNA in GBM9 GSCs transfected with control or p65/RelA siRNAs and exposed overnight to purified fibulin-3 (500 ng/mL). F–H, Expression of CSF-1 (F), CD47 (G), and TGF-β1 (H) in GBM9 cells exposed to purified fibulin-3, CAPE, or their respective vehicles. The results in all panels were analyzed by two-way ANOVA.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: